Laura Brege

Ms. Laura A. Brege is an Independent Non-Executive Director at Edgewise Therapeutics, Inc., an Independent Director at Mirum Pharmaceuticals, Inc., a Chairman at Pacira Biosciences, Inc., an Independent Director at ACADIA Pharmaceuticals, Inc. and a Chairman at Council on International Educational Exchange, Inc. She is on the Board of Directors at T-Knife Therapeutics, Inc., Edgewise Therapeutics, Inc., Mirum Pharmaceuticals, Inc., ACADIA Pharmaceuticals, Inc., Ohio University Foundation and Pacira Pharmaceuticals, Inc. (California).
Ms. Brege was previously employed as an Independent Director by HLS Therapeutics, Inc., a Managing Director by Cervantes Life Science Partners LLC, an Independent Director by Dynavax Technologies Corp., an Independent Director by Portola Pharmaceuticals LLC, an Independent Director by Aratana Therapeutics, Inc., a President, Chief Executive Officer & Director by Nodality, Inc., an Independent Director by BGH Medical Products, a Chief Operating & Business Officer, Executive VP by Onyx Pharmaceuticals, Inc., a General Partner by Red Rock Capital Management, Inc., a Chief Financial Officer & Senior Vice President by COR Therapeutics, Inc., a Chief Financial Officer & Vice President by Flextronics Corp., a Treasurer & Vice President by The Cooper Cos., Inc., and an Independent Director by The Bay Area Bioscience Association.
She also served on the board at Angiotech Pharmaceuticals, Inc., Avexus, Inc., California Life Sciences Association and StubHub Events, Inc. She received her undergraduate degree from Honors Tutorial College and an MBA from The University of Chicago Booth School of Business.